CLDN1 and colorectal cancer: In another experimental system of colorectal cancer cells expressing BRAF with V600E mutations, inhibition of the mutant BRAF by small kinase inhibitors upregulated claudin 1, which was suppressed in cells with constitutively active mutant BRAF [43].